PubRank

M Dugan

Author PubWeight™ 44.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol 2001 4.09
2 Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001 3.92
3 Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Ann Oncol 2001 3.44
4 Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 1999 3.30
5 Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin Oncol 2002 2.70
6 DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 1998 2.39
7 Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 2001 2.39
8 Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988 1.69
9 Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies. Br J Cancer 1999 1.66
10 Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Clin Cancer Res 1999 1.64
11 Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 2002 1.63
12 Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials. Ann Oncol 2005 1.57
13 Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res 1999 1.15
14 Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res 1996 1.15
15 Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies. J Clin Oncol 1999 1.11
16 Evaluating the quality of home care services using patient outcome data. Home Healthc Nurse 1996 1.09
17 UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia. Leukemia 2007 1.07
18 Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group. Br J Cancer 1998 0.99
19 Documenting the scholarship of clinical teaching through peer review. Nurse Educ 1999 0.92
20 Survival with regional and distant metastases from cutaneous malignant melanoma. Surg Gynecol Obstet 1991 0.88
21 Activity of temozolomide against human tumor colony-forming units. Clin Cancer Res 1997 0.88
22 Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. Cancer Res 1999 0.85
23 Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program. Bone Marrow Transplant 2012 0.85
24 Clinicopathologic, immunophenotypic, and molecular genetic analysis of AIDS-associated lymphoid neoplasia. Clinical and biologic implications. Pathol Annu 1988 0.82
25 Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine. Cancer Res 1991 0.81
26 Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer. Oncogene 1997 0.79
27 Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report. Gynecol Oncol 1989 0.77
28 Effects of instructed imagery on temperature on hands. Percept Mot Skills 1976 0.77
29 Scanning thermal microscopy and Raman analysis of bulk fused silica exposed to low-energy femtosecond laser pulses. Opt Express 2008 0.75
30 Comparison of the distribution of progenitor cells in G-CSF-mobilized peripheral blood and steady-state bone marrow after counterflow centrifugal elutriation. Biol Blood Marrow Transplant 1999 0.75
31 Characterization and partial purification of CD34+ progenitor cell ecto-phosphatidic acid phosphohydrolase. Biochem Mol Biol Int 1999 0.75
32 Comparing Moi-Stir to lemon-glycerin swabs. Am J Nurs 1987 0.75
33 Follow-up of the very low birth weight infant (less than 1251 grams). Minn Med 1983 0.75
34 Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence. J Hematother 1997 0.75
35 An unusual inhibition of an anti-P1. Transfusion 1981 0.75
36 Counterflow centrifugal elutriation as a method of T cell depletion may cause loss of immature CD34+ cells. Bone Marrow Transplant 1997 0.75
37 Photoreaction involving essential amino acid injection. Am J Hosp Pharm 1978 0.75